Target intelligence / Profile preview

DNA and other nucleophilic sites on macromolecules (DNA)

Target
DNA
Molecular classification
Nucleic acid, Protein, Macromolecule
01

Overview

DNA and other nucleophilic sites on macromolecules serve as the primary targets for a major class of antineoplastic agents known as alkylating and alkylating-like agents. These targets include electron-rich atoms within DNA bases—most notably the N7 position of guanine—as well as nucleophilic groups on proteins and RNA molecules. When drugs interact with these sites, they form stable covalent bonds or adducts that physically obstruct the machinery required for DNA replication and transcription. This damage often results in intra-strand or inter-strand cross-linking, leading to double-strand breaks and the activation of DNA damage response pathways. Ultimately, the accumulation of unrepaired damage triggers programmed cell death (apoptosis), making these sites critical for treating various malignancies. However, because these interactions are generally non-specific to cancer cells, they are associated with significant systemic toxicities and the risk of secondary cancers.

Other names
Genomic DNACellular macromoleculesNucleophilic targetsDNA basesDeoxyribonucleic acid
02

Mechanism of action

Covalent alkylation of nucleophilic moieties (primarily guanine N7), formation of DNA adducts, interstrand and intrastrand cross-linking, and induction of DNA strand breaks leading to apoptosis.

03

Biological functions

Genetic information storageDNA replicationRNA transcriptionProtein synthesisCellular structural integritySignal transduction
04

Disease associations

CancerAutoimmune diseaseInfection
05

Safety considerations

MyelosuppressionSecondary malignancies (e.g., Acute Myeloid Leukemia)Infertility and gonadal toxicityNephrotoxicityNeurotoxicityTeratogenicityHemorrhagic cystitis
06

Interacting drugs

Cyclophosphamide

14 more in the full profile.

07

Biomarkers

MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation statusgamma-H2AX (DNA damage marker)p53 mutation statusBRCA1/BRCA2 mutation statusDNA adduct levels

Beyond the preview

Go deeper on DNA and other nucleophilic sites on macromolecules (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA and other nucleophilic sites on macromolecules (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call